Patrick Behnke, NP
Adult Health · Chesterfield, MONPI 1417490772
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $33,600 of the $54,466 with a category attached, or 61.7%. Lilly USA, LLC accounts for 62.4% of it on its own, with 29 other manufacturers making up the rest. Among adult health clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 967 payments — averaging $56.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$34K
- Galderma Laboratories, L.p.$6K
- AbbVie$3K
- UCB, Inc.$2K
- Johnson & Johnson$1K
- Novartis$1K
- plus $7K from 24 others
What the payments were for
- Consulting fees$1,9003%
- Speaking & faculty fees$33,60062%
- Travel & lodging$3,8297%
- Food & beverage$14,43026%
- Education$7071%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 115 | $33,986 |
| Galderma Laboratories, L.p. | 39 | $6,018 |
| AbbVie | 218 | $2,841 |
| UCB, Inc. | 32 | $2,489 |
| Johnson & Johnson | 71 | $1,445 |
| Novartis | 76 | $1,151 |
| E.r. Squibb & Sons, L.L.C. | 57 | $817 |
| Pfizer | 60 | $780 |
| Arcutis Biotherapeutics, Inc. | 60 | $648 |
| Sun Pharmaceutical Industries Inc. | 24 | $631 |
| Incyte Corporation | 29 | $605 |
| Dermavant Sciences, Inc. | 48 | $511 |
| Regeneron Healthcare Solutions, Inc. | 19 | $451 |
| Amgen | 25 | $430 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 13 | $288 |
| Mayne Pharma Commercial LLC | 15 | $262 |
| Sanofi | 10 | $240 |
| Almirall LLC | 12 | $211 |
| LEO Pharma Inc. | 7 | $123 |
| Biofrontera Inc. | 9 | $122 |
| Organon | 14 | $118 |
| EPI Health, LLC | 3 | $63 |
| Kerecis Limited | 2 | $44 |
| Botanix SB Inc | 2 | $38 |
| Tactile Systems Technology Inc | 2 | $37 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $33 |
| Revance Therapeutics, Inc. | 1 | $30 |
| Strata Skin Sciences, Inc. | 1 | $24 |
| Boehringer Ingelheim | 1 | $16 |
| Journey Medical Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$54,466 in reported general payments places this provider in the 95th percentile of 555 adult health providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 15 | $314,394 |
| Taltz AutoinjectorIxekizumab | 21 | $147,927 |
| VtamaTapinarof | 14 | $19,725 |
| Clobetasol Propionate | 109 | $3,590 |
| Fluorouracil | 40 | $2,966 |
| Tacrolimus | 12 | $1,314 |
| Doxycycline Hyclate | 29 | $1,247 |
| Ketoconazole | 112 | $1,245 |
| Triamcinolone Acetonide | 74 | $877 |
| Hydroxyzine Hcl | 35 | $388 |
| Clindamycin Phosphate | 14 | $232 |
| Terbinafine Hcl | 22 | $159 |
| Prednisone | 17 | $45 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Dermavant Sciences, Inc.Vtama | $511 | $19,72514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 555 adult health providers in Missouri.
Other adult health in Chesterfield
- Tabitha StithChesterfield$300K
- Racquel FrisellaChesterfield$110K
- Kelly BeckChesterfield$8K
- Jamie JoyChesterfield$7K
- Kaitlin ThorsonChesterfield$6K
- Julie LambertChesterfield$5K
- Stephanie VogelSaint Louis$115K
- Shannon TuckerSaint Louis$93K
- Laurencia KlipfelSaint Louis$79K
- Maria WallsSaint Louis$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.